Microdose Tirzepatide + B12
Low-dose compounded tirzepatide with vitamin B12
Tirzepatide at doses below the usual starting dose, combined with vitamin B12.
About Microdose Tirzepatide + B12
Low "microdose" schedules have not been studied in clinical trials; the approved products were tested at their labeled doses.
Read the full Tirzepatide guide: research, safety and sources →
How it works
- Complete a short online visit. Answer health questions on our telehealth partner's secure site. Some treatments need lab work first.
- A licensed provider reviews it. They decide whether Microdose Tirzepatide + B12 is safe and appropriate for you and may message you with questions.
- If prescribed, it ships to you from a licensed U.S. pharmacy, with ongoing check-ins and refills through your provider.
Important safety information
Carries a boxed warning: in rodents it caused thyroid C-cell tumors. Do not use if you or a family member has had medullary thyroid carcinoma or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Nausea, vomiting, diarrhea and constipation are common. Pancreatitis, gallbladder problems, kidney problems and low blood sugar (with other diabetes medicines) can occur. Not for use during pregnancy. Compounded versions are not FDA approved, and FDA does not review them for safety, effectiveness or quality.
This is not a complete list. Your provider will review your health history, medicines and allergies before prescribing, and the pharmacy includes the full prescribing information.